Treatment of Relapsed Low-Grade or Follicular Lymphoma With Rituximab (Also Known as Rituxan, IDEC-C2B8, IDEC-102)

University of Arkansas for Medical Sciences, Little Rock

City of Hope Natioal Medical Center, Duarte

Scripps Memorial Hospital, La Jolla

UCSD Stem Cell Laboratory, La Jolla

Hoag Hospital, Newport Beach

Sutter Cancer Center, Sacramento

Sidney Kimmel Cancer Center, San Diego

University of California, San Francisco, San Francisco

Stanford University Medical Center, Stanford

Kaiser Permanente Medical Center, Vallejo

Rocky Mountain Cancer Center, Denver

Georgetown University Medical Center, Washington D.C.

Robert H. Lurie Cancer Center, Northwestern University, Chicago

University of Iowa General Hospital, Iowa City

University of Kentucky Medical Center, Lexington

Louisiana State University, Shreveport

University of Maryland Cancer Center, Baltimore

Michigan State University, East Lansing

St. Louis University Medical Center, St Louis

Roswell Park Cancer Center, Buffalo

University of Rochester Cancer Center, Rochester

Fox Chase Cancer Center, Philadelphia

University of Pittsburgh Medical Center, Pittsburgh

The West Clinic, P.C., Memphis

Texas Oncology, P.A., Dallas

M.D. Anderson Cancer Center, Houston

University of Texas Health Sciences Center, San Antonio

University of Virginia, Charlottesville

Fred Hutchinson Cancer Research Center, Seattle

Ottawa General Hospital, Ottawa

Toronto-Sunnybrook Regional Cancer Center, Toronto